Practical pharmacoeconomics. Critical evaluation of a decision-analytic model of BPH treatment options.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2000 AND VI 35 AND IP 4
Results: 24
1
2
Medications and disease states encountered at one indigent care clinic.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
3
Stroke prevention and acute intervention: review of recent advances.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
4
Focus on... Meloxicam: a COX-2-specific NSAID for the treatment of osteoarthritis.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
5
An evaluation of CYP3A4 drug interactions with HMG-CoA reductase inhibitors.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
6
Drug Watch.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 374
- Publication type:
- Article
7
New medical record privacy rules raise concerns for pharmacists, health plans.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 372
- By:
- Publication type:
- Article
8
Value of clinical pharmacist services applies to ambulatory renal transplant setting, study finds.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 369
- Publication type:
- Article
9
`Rounding down' select chemotherapy doses preserves vials, yields substantial cost savings.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 369
- Publication type:
- Article
10
Modeling software aids in NSAID cost assessment.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 367
- Publication type:
- Article
11
Managed pharmacy veteran sees shortage in P & T support staffing, questions future of drug benefit.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 367
- Publication type:
- Article
12
GP IIb/IIIa inhibitor therapy is cost-effective, but not cost-saving, in acute coronary syndromes.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 363
- Publication type:
- Article
13
Critical evaluation of a decision-analytic model of BPH treatment options.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 353
- By:
- Publication type:
- Article
14
Savings appear greater with three-tier copays than with closed formulary, health plan finds.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 363
- Publication type:
- Article
15
Medications and disease states encountered at one indigent care clinic.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 361
- By:
- Publication type:
- Article
16
An evaluation of CYP3A4 drug interactions with HMG-CoA reductase inhibitors.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 343
- By:
- Publication type:
- Article
17
Stroke prevention and acute intervention: Review of recent advances.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 328
- By:
- Publication type:
- Article
18
News IN BRIEF.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 312
- Publication type:
- Article
19
Meloxicam.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 317
- By:
- Publication type:
- Article
20
Cost-effectiveness analysis favors azithromycin over recommended regimen for hospitalized CAP...
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 311
- Publication type:
- Article
21
Antimicrobial shortages forcing widespread use of nonpreferred therapies, survey finds.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 307
- Publication type:
- Article
22
Tamoxifen for breast cancer prevention called one of the most cost-effective interventions in...
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 307
- Publication type:
- Article
23
FDA Drug Approvals.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 297
- Publication type:
- Article
24
Celexa mounts big gains among SSRIs, Thiazolidinedione market up for grabs.
- Published in:
- Formulary, 2000, v. 35, n. 4, p. 296
- Publication type:
- Article